These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 15455406

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Octreotide is not effective in the acute treatment of migraine.
    Levy MJ, Matharu MS, Bhola R, Meeran K, Goadsby PJ.
    Cephalalgia; 2005 Jan; 25(1):48-55. PubMed ID: 15606570
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S.
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
    Kudrow D, Thomas HM, Ruoff G, Ishkanian G, Sands G, Le VH, Brown MT.
    Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
    Stillman MJ, Zajac D, Rybicki LA.
    Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of acupuncture-like electrical stimulation on chronic tension-type headache: a randomized, double-blinded, placebo-controlled trial.
    Wang K, Svensson P, Arendt-Nielsen L.
    Clin J Pain; 2007 May; 23(4):316-22. PubMed ID: 17449992
    [Abstract] [Full Text] [Related]

  • 19. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
    Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, Bigal ME.
    Neurology; 2007 Aug 28; 69(9):821-6. PubMed ID: 17724283
    [Abstract] [Full Text] [Related]

  • 20. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Headache; 2005 Aug 28; 45(7):874-82. PubMed ID: 15985104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.